{"entity":{"type":"insider","cik":"0001698328","url":"/insider/0001698328","json_url":"/insider/0001698328.json","name":"Sangiovanni Timothy J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2018-10-15","last":"2026-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Sangiovanni Timothy J.","source":"filing","n_filings":8,"first_seen":"2018-10-15","last_seen":"2026-02-04"}],"transactions":[{"id":6025496,"accession":"0001698328-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001698328-26-000004","line_url":"/filing/0001698328-26-000004#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (SVP, Finance & Corp Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & Corp Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & Corp Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":9.1827,"price_display":"9.18","price_state":"stated","total_value":27548.1,"total_display":"27,548.10","total_whole":"27,548","shares_owned_after":29590.0,"shares_owned_after_display":"29,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-04","scope":"insider"},{"id":5899178,"accession":"0001698328-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001698328-26-000002","line_url":"/filing/0001698328-26-000002#line-2","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (SVP, Finance & Corp Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & Corp Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & Corp Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":8.824,"price_display":"8.82","price_state":"stated","total_value":15442.0,"total_display":"15,442.00","total_whole":"15,442","shares_owned_after":20924.0,"shares_owned_after_display":"20,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":5165652,"accession":"0001437749-25-004070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-004070","line_url":"/filing/0001437749-25-004070#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (SVP, Finance & Corp Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & Corp Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & Corp Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.8626,"price_display":"7.86","price_state":"stated","total_value":23587.8,"total_display":"23,587.80","total_whole":"23,588","shares_owned_after":16341.0,"shares_owned_after_display":"16,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider"},{"id":8207022,"accession":"0001437749-23-006278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-23-006278","line_url":"/filing/0001437749-23-006278#line-2","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (SVP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":4.1397,"price_display":"4.14","price_state":"stated","total_value":4553.67,"total_display":"4,553.67","total_whole":"4,554","shares_owned_after":4349.0,"shares_owned_after_display":"4,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-13","scope":"insider"},{"id":8207019,"accession":"0001437749-23-006278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-006278","line_url":"/filing/0001437749-23-006278#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (SVP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":4.135,"price_display":"4.14","price_state":"stated","total_value":413.5,"total_display":"413.50","total_whole":"414","shares_owned_after":4449.0,"shares_owned_after_display":"4,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-13","scope":"insider"},{"id":2126066,"accession":"0001437749-20-005367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-005367","line_url":"/filing/0001437749-20-005367#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":800.0,"total_display":"800.00","total_whole":"800","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-16","scope":"insider"},{"id":2907207,"accession":"0001437749-20-004693","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-20-004693","line_url":"/filing/0001437749-20-004693#line-3","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7657.0,"shares_display":"7,657","price_per_share":0.255,"price_display":"0.26","price_state":"stated","total_value":1952.535,"total_display":"1,952.54","total_whole":"1,953","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-10","scope":"insider"},{"id":2907203,"accession":"0001437749-20-004693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-20-004693","line_url":"/filing/0001437749-20-004693#line-2","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10.0,"shares_display":"10","price_per_share":0.2525,"price_display":"0.25","price_state":"stated","total_value":2.525,"total_display":"2.52","total_whole":"3","shares_owned_after":6343.0,"shares_owned_after_display":"6,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-10","scope":"insider"},{"id":2907199,"accession":"0001437749-20-004693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-004693","line_url":"/filing/0001437749-20-004693#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333.0,"shares_display":"333","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":83.25,"total_display":"83.25","total_whole":"83","shares_owned_after":6333.0,"shares_owned_after_display":"6,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-10","scope":"insider"},{"id":8529606,"accession":"0001437749-19-019060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-019060","line_url":"/filing/0001437749-19-019060#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.74,"price_display":"0.74","price_state":"stated","total_value":2220.0,"total_display":"2,220.00","total_whole":"2,220","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-24","filed_date":"2019-09-25","scope":"insider"},{"id":5987137,"accession":"0001437749-18-018301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-18-018301","line_url":"/filing/0001437749-18-018301#line-2","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":3750.0,"total_display":"3,750.00","total_whole":"3,750","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-12","filed_date":"2018-10-15","scope":"insider"},{"id":5987134,"accession":"0001437749-18-018301","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-18-018301","line_url":"/filing/0001437749-18-018301#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001698328","owner_name":"Sangiovanni Timothy J.","owner_display_name":"Sangiovanni Timothy J.","owner_url":"/insider/0001698328","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":3825.0,"total_display":"3,825.00","total_whole":"3,825","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-11","filed_date":"2018-10-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434647","name":"ZEVRA THERAPEUTICS, INC.","url":"/issuer/0001434647","role":"Officer (SVP, Finance & Corp Controller)","n_filings":8,"first_seen":"2018-10-15","last_seen":"2026-02-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001698328","retrieved_at":"2026-08-22T04:48:50+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}